CME Group vs MSCI
CME Group reported revenue of $6.5 billion in fiscal 2025, 2.1 times MSCI's $3.1 billion in fiscal 2025. CME Group's revenue grew 6.4% in its latest year, and MSCI's grew 9.8%. CME Group had an operating margin of 64.9%, against 54.7% at MSCI. Free cash flow was $4.2 billion at CME Group and $1.5 billion at MSCI.
Side by side
| CME Group | MSCI | |
|---|---|---|
| Latest fiscal year | FY2025, Dec 31, 2025 | FY2025, Dec 31, 2025 |
| Revenue | $6.5B | $3.1B |
| Revenue growth | 6.4% | 9.8% |
| Revenue growth a year, last 5 years | 6.0% | 13.1% |
| Gross margin | — | — |
| Operating margin | 64.9% | 54.7% |
| Net margin | 62.5% | 38.4% |
| Free cash flow | $4.2B | $1.5B |
| Free cash flow margin | 64.3% | 49.4% |
| Return on capital | 11.8% | 44.5% |
| Net debt to EBITDA | −0.3x | 3.3x |
| Dividends and buybacks | $3.9B | $3.0B |
| Change in diluted share count | 0.1% | −2.9% |
| Last close | $308.06 | $617.67 |
| P/E at the last close | 25.3× | 32.7× |
| Insider trades, last 12 months | bought $666,921, sold $30.2 million | bought $15.5 million, sold $8.8 million |
| Piotroski F-score | 7 of 8 | 7 of 8 |
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.
Ten years
Revenue
US$ billions, fiscal years
CME GroupMSCI
Operating margin
Percent of revenue
CME GroupMSCI
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
CME GroupMSCI